A. Galal, Moumen Seleet, Mohamed Kabeel, Ayman Swar
{"title":"Evaluation of DMEK with secondary IOL implantation in cases of aphakic bullous keratopathy","authors":"A. Galal, Moumen Seleet, Mohamed Kabeel, Ayman Swar","doi":"10.4103/ejos.ejos_19_23","DOIUrl":null,"url":null,"abstract":"Context DMEK is used to treat corneal decompensation. This study focuses on the succcess and outcome of DMEK with and without secondary IOL implantation. Aims The purpose of our work is to evaluate Descemet membrane endothelial keratoplasty (DMEK) with secondary Intraocular lens (IOL) implantation in cases of aphakic bullous keratopathy with insufficient capsular support. Settings and design Pilot study. Methods and material This was a nonrandomized comparative prospective interventional case series where 11 eyes of 11 patients with aphakic bullous keratopathy secondary to complicated cataract surgery underwent DMEK with secondary IOL implantation using modified Yamane technique, and results were compared to 11 eyes of 11 patients underwent DMEK only. Statistical analysis used The statistical analysis was conducted using the Statistical Package for Social Sciences (SPSS 15.0.1 for windows; SPSS Inc, Chicago, IL, 2001). Results Both groups showed a high success rate (81.8%) with rebubbling required in 3 eyes in both groups. Both groups also showed significantly improved BCVA, decreased CCT and a decrease in donor graft ECD. Conclusions DMEK combined with secondary IOL implantation by modified Yamane technique appears to be a feasible method in managing aphakic bullos keratopathy with inadequate capsular support, and results are comparable to DMEK alone.","PeriodicalId":31572,"journal":{"name":"Journal of the Egyptian Ophthalmological Society","volume":null,"pages":null},"PeriodicalIF":0.1000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Egyptian Ophthalmological Society","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ejos.ejos_19_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Context DMEK is used to treat corneal decompensation. This study focuses on the succcess and outcome of DMEK with and without secondary IOL implantation. Aims The purpose of our work is to evaluate Descemet membrane endothelial keratoplasty (DMEK) with secondary Intraocular lens (IOL) implantation in cases of aphakic bullous keratopathy with insufficient capsular support. Settings and design Pilot study. Methods and material This was a nonrandomized comparative prospective interventional case series where 11 eyes of 11 patients with aphakic bullous keratopathy secondary to complicated cataract surgery underwent DMEK with secondary IOL implantation using modified Yamane technique, and results were compared to 11 eyes of 11 patients underwent DMEK only. Statistical analysis used The statistical analysis was conducted using the Statistical Package for Social Sciences (SPSS 15.0.1 for windows; SPSS Inc, Chicago, IL, 2001). Results Both groups showed a high success rate (81.8%) with rebubbling required in 3 eyes in both groups. Both groups also showed significantly improved BCVA, decreased CCT and a decrease in donor graft ECD. Conclusions DMEK combined with secondary IOL implantation by modified Yamane technique appears to be a feasible method in managing aphakic bullos keratopathy with inadequate capsular support, and results are comparable to DMEK alone.
DMEK用于治疗角膜失代偿。本研究的重点是DMEK合并和不合并二次人工晶状体植入术的成功和结果。目的评价无晶状体大泡性角膜病变囊膜支持不足的患者行膜内皮角膜移植术(DMEK)联合继发性人工晶状体植入术的疗效。试验研究。方法和材料:本研究是一项非随机对照前瞻性介入病例系列研究,11例复杂性白内障术后继发无晶状体大泡性角膜病变患者的11只眼采用改良Yamane技术行DMEK合并二次人工晶状体植入术,并将结果与11例仅行DMEK的11只眼进行比较。统计分析采用SPSS 15.0.1 for windows;SPSS公司,芝加哥,伊利诺伊州,2001)。结果两组手术成功率均为81.8%,均有3只眼需要再泡。两组患者BCVA均显著改善,CCT降低,供体ECD降低。结论DMEK联合改良Yamane技术二次人工晶状体植入术是治疗无囊性大疱性角膜病变的可行方法,其效果与DMEK单独植入术相当。